Search
Sol Gel Technologies Ltd
SLGLAdd to Watchlist
73.020USD
-1.440-1.93%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
238.70MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-22The current earnings forecast score of Sol Gel Technologies Ltd is 8.00, ranking 164 out of 389 in the Biotechnology & Medical Research industry. The average price target is 50.00, with a high of 50.00 and a low of 50.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
147.000
Target Price
+97.42%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Sol Gel Technologies Ltd
SLGL
3
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Sol Gel Technologies Ltd's expected revenue for the next quarter?
Sol Gel Technologies Ltd's expected revenue is 1.20M.
What is Sol Gel Technologies Ltd's price target?
Analysts forecast that Sol Gel Technologies Ltd's price target is USD 50.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 50.00.
How have Sol Gel Technologies LtdSLGL's recent earnings per share performed?
The market expectation was USD -1.31, while Sol Gel Technologies LtdSLGL's earnings per share (EPS) for the previous quarter was USD -1.07. EPS for the next quarter is expected at USD -2.57.
What is the analyst rating for Sol Gel Technologies Ltd?
Based on the ratings of Sol Gel Technologies Ltd's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
